Endocrine Abstracts

Introduction: Pituitary carcinomas are rare and their management is difficult, because they exhibit a continued growth and metastatic dissemination despite of multimodal and aggressive treatments. Temozolamide, has shown a substantial response rates in pituitary carcinomas.We report the case of a patient with a malignant prolactinoma successfully treated with temozolamide.Case report: The patient, a 62-year-old male, consulted with...